Thiruvananthapuram: Indian Council of Medical Research (ICMR) Director General Dr Balram Bhargava has stated interim outcomes of the continued medical trials indicated that the indigenous Covid-19 vaccines would be effective against the mutated virus strains reported from the United Kingdom, South Africa and Brazil.
A paper on Covaxin’s neutralisation potential against the UK pressure has been accepted for publication, he stated right here on Thursday whereas addressing a world webinar “Kerala Health: Making the SDG A Reality,”organised by the Department of Health and Family Welfare, Government of Kerala.
In the case of the variants from South Africa and Brazil, efforts have been on to isolate the mutated virus strains from the samples collected from travellers from these two international locations, he stated.
The official stated the third medical trial of Covaxin BB152 had been accomplished as all of the 25,800 volunteers concerned within the train had been administered each the doses.
“The interim analysis report should be out in a week,” he stated.
Dr Bhargava identified that India was the fifth nation on this planet to isolate the Covid-19 virus as a part of the efforts to develop a vaccine for the pandemic.
With its graded response to the outbreak of Covid-19 proper from the start, India had efficiently saved the unfold of the pandemic underneath management whereas utilising this era for drastically scaling up the capability of the nation’s medical infrastructure, each underneath the federal government and the non-public sector.
India had from the outset resisted the temptation of going for herd immunity not like many European international locations, together with the UK and Italy, and its determination had been vindicated from what occurred within the western nations that allowed the pandemic to unfold, he identified.
As a consequence, India had not solely ramped up its medical infrastructure for home use however had additionally reached the extent of exporting vaccines and remedy kits on a big scale, he stated.
The webinar sequence that started on February 17, with deal with the prospects of attaining sustainable growth targets (SDGs) amid an added problem posed by Covid-19, is held throughout 5 days this month and early March.